ACS


ACS raises 2026 guidance

30/07/26 -"ACS reported Q2 results broadly in line with expectations and raised guidance, helped again by Turner and the US data-centre cycle. H1 operational net profit rose 30% to €510m, slightly ahead of the ..."

Pages
45
Language
English
Published on
30/07/26
You may also be interested by these reports :
04/08/26
Royal BAM raised its 2026 adjusted EBITDA margin guidance to at least 6.5% after H1 revenue rose 3% to €3.49bn and EBITDA increased by 36% to €240m, ...

31/07/26
Sacyr increased H1 revenue by 9.0% to €2.44bn and EBITDA by 9.4% to €708m, but the 157% rise in attributable profit to €78m gives the wrong ...

30/07/26
ACS reported Q2 results broadly in line with expectations and raised guidance, helped again by Turner and the US data-centre cycle. H1 operational ...

30/07/26
VINCI protected earnings despite weaker concession volumes. Revenue rose 2.1% to €35.6bn, while EBITDA increased by 4.5% and EPS by 10.8%. Cost ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO